Start Date
October 31, 1999
filgrastim
docetaxel
gemcitabine hydrochloride
Washington Cancer Institute, Washington D.C.
St. Joseph Medical Center, Towson
Northern Virginia Oncology Group, Fairfax
Center for Hematology-Oncology, Boca Raton
Memphis Cancer Center, Inc., Memphis
Hematology & Oncology Associates of Southern Michigan, Jackson
Oncology-Hematology Associates of North Illinois, Ltd., Gurnee
Arlington Cancer Center, Arlington
University of California San Diego, La Jolla
Sacramento Center for Hematology and Medical Oncology, Sacramento
Maine Center for Cancer Medicine and Blood Disorders, Scarborough
Hematology Oncology Associates of Central New York, Syracuse
Lead Sponsor
Amgen
INDUSTRY